Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Clinicopathological study of SDHB mutation-related pheochromocytoma and sympathetic paraganglioma.

Kimura N, Takekoshi K, Horii A, Morimoto R, Imai T, Oki Y, Saito T, Midorikawa S, Arao T, Sugisawa C, Yamada M, Otuka Y, Kurihara I, Sugano K, Nakane M, Fukuuchi A, Kitamoto T, Saito J, Nishikawa T, Naruse M.

Endocr Relat Cancer. 2014 May 6;21(3):L13-6. doi: 10.1530/ERC-13-0530. Print 2014 Jun. No abstract available.

2.

Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma.

Kimura N, Takayanagi R, Takizawa N, Itagaki E, Katabami T, Kakoi N, Rakugi H, Ikeda Y, Tanabe A, Nigawara T, Ito S, Kimura I, Naruse M; Phaeochromocytoma Study Group in Japan.

Endocr Relat Cancer. 2014 May 6;21(3):405-14. doi: 10.1530/ERC-13-0494. Print 2014 Jun.

3.

Neuroendocrine cancer. Closing the GAPP on predicting metastases.

Eisenhofer G, Tischler AS.

Nat Rev Endocrinol. 2014 Jun;10(6):315-6. doi: 10.1038/nrendo.2014.41. Epub 2014 Apr 1.

PMID:
24686203
4.

Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status.

Eisenhofer G, Lenders JW, Siegert G, Bornstein SR, Friberg P, Milosevic D, Mannelli M, Linehan WM, Adams K, Timmers HJ, Pacak K.

Eur J Cancer. 2012 Jul;48(11):1739-49. doi: 10.1016/j.ejca.2011.07.016. Epub 2011 Oct 28.

5.

Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.

Bayley JP, van Minderhout I, Weiss MM, Jansen JC, Oomen PH, Menko FH, Pasini B, Ferrando B, Wong N, Alpert LC, Williams R, Blair E, Devilee P, Taschner PE.

BMC Med Genet. 2006 Jan 11;7:1.

6.

Germline SDHB mutations are common in patients with apparently sporadic sympathetic paragangliomas.

Klein RD, Jin L, Rumilla K, Young WF Jr, Lloyd RV.

Diagn Mol Pathol. 2008 Jun;17(2):94-100. doi: 10.1097/PDM.0b013e318150d67c.

PMID:
18382370
7.

Paraganglioma and pheochromocytoma upon maternal transmission of SDHD mutations.

Bayley JP, Oldenburg RA, Nuk J, Hoekstra AS, van der Meer CA, Korpershoek E, McGillivray B, Corssmit EP, Dinjens WN, de Krijger RR, Devilee P, Jansen JC, Hes FJ.

BMC Med Genet. 2014 Oct 10;15:111. doi: 10.1186/s12881-014-0111-8.

8.

Validation of pathological grading systems for predicting metastatic potential in pheochromocytoma and paraganglioma.

Koh JM, Ahn SH, Kim H, Kim BJ, Sung TY, Kim YH, Hong SJ, Song DE, Lee SH.

PLoS One. 2017 Nov 8;12(11):e0187398. doi: 10.1371/journal.pone.0187398. eCollection 2017.

9.

No child left behind in SDHB testing for paragangliomas and pheochromocytomas.

Schiffman JD.

J Clin Oncol. 2011 Nov 1;29(31):4070-2. doi: 10.1200/JCO.2011.37.8695. Epub 2011 Oct 3. No abstract available.

PMID:
21969491
10.

[Phaeochromocytoma associated with a paraganglion syndrome].

Moreno Tejero ML, Pintor Trevejo M, Martín Ruiz C, Galán Gómez E.

An Pediatr (Barc). 2008 May;68(5):527-9. Spanish. No abstract available.

11.

Hereditary paraganglioma due to the SDHD M1I mutation in a second Chinese family: a founder effect?

Lee SC, Chionh SB, Chong SM, Taschner PE.

Laryngoscope. 2003 Jun;113(6):1055-8.

PMID:
12782822
12.

Role of microenvironment on neuroblastoma SK-N-AS SDHB-silenced cell metabolism and function.

Rapizzi E, Fucci R, Giannoni E, Canu L, Richter S, Cirri P, Mannelli M.

Endocr Relat Cancer. 2015 Jun;22(3):409-17. doi: 10.1530/ERC-14-0479. Epub 2015 Mar 25.

13.

Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma.

Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, George E, Sköldberg F, Husebye ES, Eng C, Maher ER.

Am J Hum Genet. 2001 Jul;69(1):49-54. Epub 2001 Jun 12. Erratum in: Am J Hum Genet 2002 Feb;70(2):565.

14.

Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes.

Gill AJ, Benn DE, Chou A, Clarkson A, Muljono A, Meyer-Rochow GY, Richardson AL, Sidhu SB, Robinson BG, Clifton-Bligh RJ.

Hum Pathol. 2010 Jun;41(6):805-14. doi: 10.1016/j.humpath.2009.12.005. Epub 2010 Mar 17.

PMID:
20236688
15.

Mutation analysis of the SDHB and SDHD genes in pheochromocytomas and paragangliomas: identification of a novel nonsense mutation (Q168X) in the SDHB gene.

Oishi Y, Nagai S, Yoshida M, Fujisawa S, Sazawa A, Shinohara N, Nonomura K, Matsuno K, Shimizu C.

Endocr J. 2010;57(8):745-50. Epub 2010 May 25.

16.

The first Dutch SDHB founder deletion in paraganglioma-pheochromocytoma patients.

Bayley JP, Grimbergen AE, van Bunderen PA, van der Wielen M, Kunst HP, Lenders JW, Jansen JC, Dullaart RP, Devilee P, Corssmit EP, Vriends AH, Losekoot M, Weiss MM.

BMC Med Genet. 2009 Apr 15;10:34. doi: 10.1186/1471-2350-10-34.

17.

A founder SDHB mutation in Portuguese paraganglioma patients.

Martins RG, Nunes JB, Máximo V, Soares P, Peixoto J, Catarino T, Rito T, Soares P, Pereira L, Sobrinho-Simões M, Santos AP, Couto J, Henrique R, Matos-Loureiro J, Dias P, Torres I, Lima J.

Endocr Relat Cancer. 2013 Nov 4;20(6):L23-6. doi: 10.1530/ERC-12-0399. Print 2013 Dec. No abstract available.

18.

Warburg effect's manifestation in aggressive pheochromocytomas and paragangliomas: insights from a mouse cell model applied to human tumor tissue.

Fliedner SM, Kaludercic N, Jiang XS, Hansikova H, Hajkova Z, Sladkova J, Limpuangthip A, Backlund PS, Wesley R, Martiniova L, Jochmanova I, Lendvai NK, Breza J, Yergey AL, Paolocci N, Tischler AS, Zeman J, Porter FD, Lehnert H, Pacak K.

PLoS One. 2012;7(7):e40949. doi: 10.1371/journal.pone.0040949. Epub 2012 Jul 31.

19.

Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: a possible hot spot?

Cascón A, Montero-Conde C, Ruiz-Llorente S, Mercadillo F, Letón R, Rodríguez-Antona C, Martínez-Delgado B, Delgado M, Díez A, Rovira A, Díaz JA, Robledo M.

Genes Chromosomes Cancer. 2006 Mar;45(3):213-9.

PMID:
16258955
20.

Long-term prognosis of patients with pediatric pheochromocytoma.

Bausch B, Wellner U, Bausch D, Schiavi F, Barontini M, Sanso G, Walz MK, Peczkowska M, Weryha G, Dall'igna P, Cecchetto G, Bisogno G, Moeller LC, Bockenhauer D, Patocs A, Rácz K, Zabolotnyi D, Yaremchuk S, Dzivite-Krisane I, Castinetti F, Taieb D, Malinoc A, von Dobschuetz E, Roessler J, Schmid KW, Opocher G, Eng C, Neumann HP.

Endocr Relat Cancer. 2013 Dec 16;21(1):17-25. doi: 10.1530/ERC-13-0415. Print 2014 Feb.

Supplemental Content

Support Center